CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer

Rony K. Roy, Michal M. Hoppe, Supriya Srivastava, Animesh Samanta, Neel Sharma, Kar Tong Tan, Henry Yang, Dominic C Voon, Brendan Pang, Ming Teh, Naoko Murata-Kamiya, Masanori Hatakeyama, Young-Tae Chang, Wei Peng Yong, Yoshiaki Ito, Khek Yu Ho, Patrick Tan, Richie Soong, Phillip H. Koeffler, Khay Guan YeohAnand D. Jeyasekharan, Neel Sharma

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
158 Downloads (Pure)

Abstract

Early detection of gastric cancers saves lives, but remains a diagnostic challenge. In this study, we aimed to identify cell-surface biomarkers of early gastric cancer. We hypothesized that a subset of plasma membrane proteins induced by the Helicobacter pylori oncoprotein CagA will be retained in early gastric cancers through non-oncogene addiction. An inducible system for expression of CagA was used to identify differentially upregulated membrane protein transcripts in vitro. The top hits were then analyzed in gene expression datasets comparing transcriptome of gastric cancer with normal tissue, to focus on markers retained in cancer. Among the transcripts enriched upon CagA induction in vitro, a significant elevation of CEACAM6 was noted in gene expression datasets of gastric cancer. We used quantitative digital immunohistochemistry to measure CEACAM6 protein levels in tissue microarrays of gastric cancer. We demonstrate an increase in CEACAM6 in early gastric cancers, when compared to matched normal tissue, with an AUC of 0.83 for diagnostic validity. Finally, we show that a fluorescently conjugated CEACAM6 antibody binds avidly to freshly resected gastric cancer xenograft samples and can be detected by endoscopy in real time. Together, these results suggest that CEACAM6 upregulation is a cell surface response to H. pylori CagA, and is retained in early gastric cancers. They highlight a novel link between CEACAM6 expression and CagA in gastric cancer, and suggest CEACAM6 to be a promising biomarker to aid with the fluorescent endoscopic diagnosis of early neoplastic lesions in the stomach.

Original languageEnglish
Pages (from-to)55290-55301
Number of pages12
JournalOncoTarget
Volume7
Issue number34
DOIs
Publication statusPublished - 11 Jul 2016

Keywords

  • Animals
  • Antigens, Bacterial/physiology
  • Antigens, CD/analysis
  • Bacterial Proteins/physiology
  • Biomarkers, Tumor/analysis
  • Cell Adhesion Molecules/analysis
  • Fluorescent Antibody Technique
  • GPI-Linked Proteins/analysis
  • Helicobacter Infections/metabolism
  • Humans
  • Mice
  • Stomach Neoplasms/diagnosis
  • Up-Regulation

Fingerprint

Dive into the research topics of 'CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer'. Together they form a unique fingerprint.

Cite this